Nanni Schmitt Selected Research

Fas Ligand Protein (Fas Ligand)

2/2024

Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nanni Schmitt Research Topics

Disease

4	Neoplasms (Cancer) 02/2024 - 01/2023
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2023 - 11/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023
1	Carcinogenesis 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Iron Overload 01/2021

Drug/Important Bio-Agent (IBA)

2	Azacitidine (5 Azacytidine)FDA Link 11/2023 - 01/2023
1	APG101IBA 02/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024
1	Fas Ligand Protein (Fas Ligand)IBA 02/2024
1	alvocidib (flavopiridol)IBA 11/2023
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	eltrombopag FDA Link 01/2022
1	RNA Splicing FactorsIBA 11/2021
1	IronIBA 01/2021

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 11/2023
1	Heterologous Transplantation (Xenotransplantation) 01/2022